8-K: NeOnc Technologies Secures $1M in Latest Equity Offering

NeOnc Technologies Holdings, Inc. completed an initial closing of its third Securities Purchase Agreement, raising $1 million through the issuance of common stock and warrants.

Summary

• NeOnc Technologies Holdings, Inc. (NTHI) entered into a third Securities Purchase Agreement on March 20, 2026, to issue and sell up to 545,583 shares of common stock and an equal number of five-year warrants.
• The initial closing under this third agreement, also on March 20, 2026, raised $1,000,000 from one institutional investor.
• This closing involved the issuance of 138,889 shares of common stock at a purchase price of $7.20 per share.
• Concurrently, 138,889 five-year warrants were issued, each exercisable at $9.00 per share, with a commencement date of March 20, 2026, and an expiration date of March 20, 2031.
• The offering under this third Securities Purchase Agreement is set to terminate on April 30, 2026, allowing for potential further closings.
• Proceeds from this offering are intended for working capital purposes.
• The securities were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
• A resale registration statement for these shares and warrant shares will be filed no later than ten days after the company's Annual Report on Form 10-K for the year ended December 31, 2025, is filed.
• Previously, under a first Securities Purchase Agreement (January 29, 2026), the company issued 1,475,249 shares and warrants for an aggregate of $10,621,804.11.
• Under a second Securities Purchase Agreement (February 24, 2026), the company issued 201,390 shares and warrants for $1,450,004.
• Cumulatively, across all three agreements to date, the company has issued 1,815,528 shares and warrants, raising a total of $13,071,808.11.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it secures additional working capital for the company, which is crucial for operations. However, the associated dilution from new share issuance and potential future warrant exercises tempers the overall sentiment.

Positives

• Secured an additional $1,000,000 in capital, contributing to the company's working capital.
• The company continues to successfully execute its financing strategy through equity offerings, demonstrating access to capital markets.
• The issuance of warrants provides potential for future capital infusion if exercised.

Negatives

• The issuance of 138,889 new shares of common stock results in immediate dilution for existing shareholders.
• The 138,889 warrants represent potential future dilution if and when they are exercised.
• The offering price of $7.20 per share is below the warrant exercise price of $9.00, indicating a discount for the immediate share purchase.

Risks

• The issued securities are unregistered and subject to resale restrictions, requiring an effective registration statement or an available exemption for transfer.
• Beneficial ownership limitations (4.99%) may restrict a holder's ability to fully exercise warrants if it would exceed this threshold, potentially impacting liquidity for large investors.
• Future equity sales at lower prices could trigger anti-dilution adjustments to the warrant exercise price, potentially increasing the number of shares issuable upon exercise and further diluting existing shareholders.
• The fair market value of shares, used for cashless exercise, is subject to market fluctuations, which could impact the value received by warrant holders.
• The company must maintain compliance with Nasdaq listing requirements, and any failure could adversely affect share liquidity.

Future Outlook

The company plans to use the net proceeds from this offering for working capital purposes. A resale registration statement for the shares and warrant shares will be filed no later than ten days after the filing of the company's Annual Report on Form 10-K for the year ended December 31, 2025, to facilitate their public resale.

Management Comments

• The Company intends to use the net proceeds from the offering for working capital purposes.

Industry Context

StockSavvy.ai notes that this capital raise is a common strategy for growth-oriented companies like NeOnc Technologies to fund ongoing operations and strategic initiatives. The structure of issuing both common stock and warrants is typical for private placements, balancing immediate capital needs with future upside potential for investors, albeit at the cost of dilution for existing shareholders.

Stakeholder Impact

• Shareholders: Experience immediate dilution from the issuance of new common stock and potential future dilution from warrant exercises.
• Company: Gains additional working capital to fund operations and strategic initiatives.
• Investors (purchasers of securities): Acquire common stock at a discount and warrants with future upside potential, subject to beneficial ownership limitations and resale restrictions.

Next Steps

• Potential for subsequent closings under the third Securities Purchase Agreement until April 30, 2026.
• The company will file a resale registration statement for the issued shares and warrant shares within 10 days after filing its Annual Report on Form 10-K for the year ended December 31, 2025.

Key Dates

Recommendation

The filing details a capital raise that provides necessary working capital, which is a positive for the company's operational stability. However, the issuance of new shares and warrants introduces dilution for existing shareholders. Without further operational or financial performance updates, this financing event primarily maintains the company's liquidity, suggesting a 'hold' for existing investors rather than a strong 'buy' or 'sell' signal based solely on this filing.

Keywords

NeOnc Technologies, NTHI, equity offering, warrants, capital raise, securities purchase agreement, common stock, dilution, working capital, SEC filing, Nasdaq